Which breathing aid works best for kids? new study compares HVNI and CPAP

NCT ID NCT07336121

Completed Symptom relief Sponsor: Ain Shams University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 80 children aged 1 month to 5 years with severe breathing problems from pneumonia or bronchiolitis. It compared two non-invasive breathing support methods: High Velocity Nasal Insufflation (HVNI) and Nasal Continuous Positive Airway Pressure (CPAP). The goal was to see which method improves lung function better and is more comfortable for children, using daily lung ultrasound scores and clinical assessments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: High Velocity Nasal Insufflation (HVNI) and Nasal Continuous Positive Airway Pressure (CPAP) devices
What this could lead to: If this study shows one method is better, it could help doctors choose the most effective and comfortable breathing support for young children with breathing problems.
What could go wrong: This is a small, completed study with only 80 children, so results may not apply to all kids. The devices are already in use, so no major new risks are expected, but the study may not find a clear winner.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute respiratory distress syndrome bronchiolitis Community-Acquired Pneumonia pneumonia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRONCHIOLITIS COMMUNITY-ACQUIRED PNEUMONIA

Contacts and locations

Locations

Pediatric Intensive Care Units, Children Hospital, Ain shams university

Cairo, 00002, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.